Published in Kidney Int on January 01, 1999
MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy. FASEB J (2008) 2.75
The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes (2010) 2.00
The influence of pre-existing diabetes mellitus on the host immune response and outcome of pneumonia: analysis of two multicentre cohort studies. Thorax (2010) 1.31
Hypertension in diabetic nephropathy: epidemiology, mechanisms, and management. Adv Chronic Kidney Dis (2011) 1.18
Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment. J Natl Med Assoc (2004) 1.04
Diabetic nephropathy: Is it time yet for routine kidney biopsy? World J Diabetes (2013) 0.98
Nephroprotection in Zucker diabetic fatty rats by vasopeptidase inhibition is partly bradykinin B2 receptor dependent. Br J Pharmacol (2004) 0.91
Diabetic nephropathy: prescription trends in tertiary care. Indian J Pharm Sci (2010) 0.89
Establishment of a diabetic mouse model with progressive diabetic nephropathy. Am J Pathol (2005) 0.89
Non-Proteinuric Diabetic Nephropathy. J Clin Med (2015) 0.89
Mitigating micro-and macro-vascular complications of diabetes beginning in adolescence. Vasc Health Risk Manag (2009) 0.83
[Characteristics of the association type 2 diabetes and hypertension in the elderly aged 65 and over]. Pan Afr Med J (2013) 0.80
Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy. J Diabetes Res (2016) 0.78
Hypertension, poor glycemic control, and microalbuminuria in Cuban Americans with type 2 diabetes. Int J Nephrol Renovasc Dis (2011) 0.77
Role of mindin in diabetic nephropathy. Exp Diabetes Res (2011) 0.77
Sodium-Glucose Cotransporter-2 Inhibition and the Glomerulus: A Review. Adv Ther (2016) 0.77
Aminaphtone therapy in patients with type 1 diabetes and albuminuria: a case report. J Med Case Rep (2014) 0.75
Factors of cardiovascular risk in patients with type 2 diabetes and incipient nephropathy. Hippokratia (2008) 0.75
Impact of diabetes-related gene polymorphisms on the clinical characteristics of type 2 diabetes Chinese Han population. Oncotarget (2016) 0.75
Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes. Diabetologia (2017) 0.75
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
The construct of resilience: a critical evaluation and guidelines for future work. Child Dev (2000) 12.08
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
Evaluating the effects of a brief motivational intervention for injured drinkers in the emergency department. J Stud Alcohol (2001) 3.59
The nephrotic syndrome. N Engl J Med (1998) 3.22
Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet (1998) 2.98
Assembling the presynaptic active zone: a characterization of an active one precursor vesicle. Neuron (2001) 2.52
Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis (2001) 2.42
Hantavirus infection presenting as acute renal failure. Lancet (1990) 2.40
Molecular characterization and spatial distribution of SAP97, a novel presynaptic protein homologous to SAP90 and the Drosophila discs-large tumor suppressor protein. J Neurosci (1995) 2.40
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant (2000) 2.38
Diabetes mellitus and primary open-angle glaucoma. The XXVII Edward Jackson Memorial Lecture. Am J Ophthalmol (1971) 2.37
Biostatistical analysis of the collaborative glaucoma study. I. Summary report of the risk factors for glaucomatous visual-field defects. Arch Ophthalmol (1980) 2.28
The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis. Nephrol Dial Transplant (1995) 2.06
Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest (1989) 1.98
The onset and evolution of glaucomatous visual field defects. Ophthalmology (1982) 1.97
Pilocarpine therapy with soft contact lenses. Am J Ophthalmol (1972) 1.97
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int (2007) 1.83
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int (1998) 1.77
Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant (1998) 1.71
Injury as a motivator to reduce drinking. Acad Emerg Med (1995) 1.65
Cloning and sequencing of rat plectin indicates a 466-kD polypeptide chain with a three-domain structure based on a central alpha-helical coiled coil. J Cell Biol (1991) 1.62
Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Investig (1992) 1.61
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int (1998) 1.61
Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost (1984) 1.59
Q-T prolongation and polymorphous ("torsade de pointes") ventricular arrhythmias associated with organophosphorus insecticide poisoning. Am J Cardiol (1982) 1.59
Centers of rotation with transverse forces: an experimental study. Am J Orthod Dentofacial Orthop (1991) 1.59
Export of cellubrevin from the endoplasmic reticulum is controlled by BAP31. J Cell Biol (1997) 1.56
Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc Natl Acad Sci U S A (1999) 1.54
Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant (1995) 1.54
Elevation of intraocular pressure by calcium channel blockers. Arch Ophthalmol (1984) 1.51
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int (2001) 1.49
The long-term effects of iridectomy for primary acute angle-closure glaucoma. Am J Ophthalmol (1978) 1.49
In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol (1997) 1.48
Multivariate analysis of the risk of glaucomatous visual field loss. Arch Ophthalmol (1979) 1.44
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. Nephrol Dial Transplant (2000) 1.43
Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Perit Dial Int (1996) 1.42
Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. Nephron (1994) 1.42
The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. Nephrol Dial Transplant (1992) 1.41
Parathyroidectomy in secondary (renal) hyperparathyroidism--whom, when, how? Int J Artif Organs (1993) 1.41
[Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy]. Dtsch Med Wochenschr (1995) 1.40
Horseshoe kidney. Nephrol Dial Transplant (1999) 1.40
[Routine screening for microalbuminemia in type 2 diabetes mellitus--pro]. Dtsch Med Wochenschr (2003) 1.39
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]. Dtsch Med Wochenschr (2004) 1.39
Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? Nephrol Dial Transplant (1991) 1.38
[The quality of the treatment of diabetics in kidney failure in Germany]. Dtsch Med Wochenschr (2000) 1.38
Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats. Eur J Clin Invest (1999) 1.38
Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) Eur J Clin Invest (1989) 1.38
Analgesic nephropathy. Nephrol Dial Transplant (1996) 1.38
Plectin transcript diversity: identification and tissue distribution of variants with distinct first coding exons and rodless isoforms. Genomics (1997) 1.38
Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol (1998) 1.37
The Normal Haematocrit Trial in dialysis patients with cardiac disease: are we any the less confused about target haemoglobin? Nephrol Dial Transplant (1998) 1.36
Bone histology in incipient and advanced renal failure. Kidney Int (1976) 1.35
Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr (1974) 1.34
Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int (1998) 1.32
Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure. J Am Soc Nephrol (2000) 1.32
Frusemide therapy and intact parathyroid hormone plasma concentrations in chronic renal insufficiency. Nephrol Dial Transplant (1992) 1.30
Effects of exercise on aqueous dynamics. Am J Ophthalmol (1970) 1.30
Intraocular pressure response to topical corticosteroids. Fed Proc (1966) 1.30
Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant (1990) 1.30
Valve implants in filtering surgery. Am J Ophthalmol (1976) 1.29
Prognostic significance of optic disk cupping in ocular hypertensive patients. Am J Ophthalmol (1980) 1.29
The effect of exercise on intraocular pressure. I. Human beings. Invest Ophthalmol (1970) 1.28
1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood (1993) 1.28
Primary open-angle glaucoma in adolescents and young adults. Arch Ophthalmol (1970) 1.28
Myocardial interstitial fibrosis in experimental uremia--implications for cardiac compliance. Kidney Int (1988) 1.27
Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int (1997) 1.27
Association of chronic kidney graft failure with recipient blood pressure. Collaborative Transplant Study. Kidney Int (1998) 1.26
The specificity of association of the IgD molecule with the accessory proteins BAP31/BAP29 lies in the IgD transmembrane sequence. EMBO J (1996) 1.25
Renal functional reserve in healthy elderly subjects. J Am Soc Nephrol (1993) 1.24
Complement membrane attack (MAC) in idiopathic IgA-glomerulonephritis. Kidney Int (1987) 1.24
Retinoic acid reduces glomerular injury in a rat model of glomerular damage. J Am Soc Nephrol (2000) 1.24
Family history in primary open-angle glaucoma. Arch Ophthalmol (1977) 1.24
Anterograde transport of algal scales through the Golgi complex is not mediated by vesicles. Trends Cell Biol (1995) 1.23
Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol (1991) 1.23
Acquired renal cysts in uremic patients--in vivo demonstration by computed tomography. Clin Nephrol (1980) 1.22
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch Ophthalmol (1989) 1.22
Prognostic indicators in ocular hypertension. Arch Ophthalmol (1974) 1.21
Necrotizing dermatitis resulting from hemodialysis with polyvinylchloride tubing. Ann Intern Med (1979) 1.21
A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics. Exp Eye Res (1978) 1.21
Is vasculitis in subacute bacterial endocarditis associated with ANCA? Lancet (1991) 1.20
Acute renal failure, hypertension and skin necrosis in a patient with streptokinase therapy. Am J Nephrol (1984) 1.20
Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol (2002) 1.20
Audit of antihypertensive treatment in patients with renal failure. Nephrol Dial Transplant (1998) 1.19
Skeletal abnormalities in chronic renal insufficiency before and during maintenance hemodialysis. Kidney Int (1973) 1.18
Mechanism of cephalosporin-induced hypoprothrombinemia: relation to cephalosporin side chain, vitamin K metabolism, and vitamin K status. J Clin Pharmacol (1988) 1.17
Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transplant (1989) 1.17
A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol (1994) 1.17
Epinephrine maculopathy. Arch Ophthalmol (1968) 1.17
1,25(OH)2 vitamin D3 inhibits parathyroid cell proliferation in experimental uremia. Kidney Int (1989) 1.16
Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy. Q J Med (1970) 1.15
Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer. J Clin Oncol (1985) 1.15
Prognostic factors in glaucomatous visual field loss. Arch Ophthalmol (1976) 1.15
ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy. Diabetologia (2003) 1.14